Will it be as tools to better classify patients into the different phases of disease - from immune-tolerant to chronic hepatitis to inactive carriers, and so on? That will be one possibility, and we need to do more ...
Diagnosis ofHCC should be based on imaging techniques and/orbiopsy.The 2005 diagnostic algorithm has been vali-dated and the diagnostic accuracy of a single dynamicSurveillanceistechnique showing intense arterial uptake followed by‘‘washout’’ of contrast in the venous-delayed phases hasbeen ...
The primary outcome was adherence to five areas of the AASLD guidelines: (i) timely alanine aminotransferase (ALT)/hepatitis B virus DNA level checks needed to monitor inactive carrier and immune-tolerant phases; (ii) liver biopsy to guide decisions on initiating treatment; (iii) tre...